NASDAQ:MORF
Delisted

Morphic Holding Stock Signals

etoro logo Buy MORF
*Your capital is at risk
$56.99
+0 (+0%)
At Close: Nov 14, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Morphic Holding, Inc.

General

Signal Type Signal Value Data
Score 0.000 102 days ( -81.55 %
Last Price $56.99 0 %
Performance History
7 Days
$56.99 $56.99
0%
30 Days
$56.99 $56.99
0%
12 Mos
$23.28 $56.99
144.80%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $56.99 - $56.99
Trend - 3 mos 0 % High Width: 0.00000000000035 %
Pred. range - 3 mos $56.99 - $56.99 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Nov 13, 2024 - 2 days
RSI Short Pivot Signal Sell Very Low Aug 23, 2024 - 59 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 74.41
Signal Type Signal Value Importance Data
Trend - 12 mos 119.23 % Very High Width: 66.03 %
Pred. range - 12 mos $92.02 - $152.78 High 61.47 % - 168.08 %
Short MA 12 mos Buy Very High Jun 21, 2024 - 103 days
Long MA 12 mos Buy Very High Jul 03, 2024 - 95 days
Short/Long MA 12 mos Buy Very High Jul 08, 2024 - 93 days
Pivot Long Sell Low Nov 13, 2024 - 2 days
RSI Long Pivot Signal Sell Low Sep 04, 2024 - 52 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT MORPHIC HOLDING, INC.
Morphic Holding
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmo...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE